SAHARA ANNOUNCES THE UPDATES REGARDING THE USE OF PROCEEDS FROM THE RIGHTS ISSUE

26/01/2014 Tadawul

Sahara announces to its shareholders the developments of proceeds from the rights issue received on 23/12/2011G. Up to the end of the 3rd quarter of 2013 the company has used the following amounts to finance the projects listed in the prospectus as follows:

- ALWAHA Petrochemicals Company: Zero
- SAHARA & Ma,aden Petrochemicals Company-SAMAPCO: SAR 52,330,000
- Saudi Acrylic Polymer Company-SAPCO: SAR 95,110,000
- Saudi Acrylic Monomer Company-SAMCO: Zero
- Neopentyl Glycol-NPG: SAR 110,000
- Butanol Project: SAR 74,840,000
- Utilities and off sites (U&O): SAR 164,670,000
- Administrative expenses related to Sahara Petrochemicals Company for five years: SAR 45,780,000
- Employee Home Ownership Program Financing Costs: Zero
- Adjustments Requests to support shared services: SAR 17,540,000
- Contingency (General): SAR 10,330,000
- Rights Issue Shares Financing Cost: SAR 31,920,000
- Short Term Bridge Loan repayment: SAR 384,770,000
- Employee Share Incentive Program: 5,900,000

It is worth mentioning that the subscription proceeds amounted to SAR 1,462,650,000 (One billion and four hundred sixty two million and six hundred fifty thousand Saudi Riyal) of which SAR 883,300,000 (Eight hundred eighty three million and three hundred thousand Saudi Riyal) were already used as of end of the 4th Quarter ,2013.

The remaining balance of the subscription proceeds is SAR 579,350,000 (Five hundred and seventy nine million and three hundred fifty thousand Saudi Riyal).No proceeds were used in any other aspect other than mentioned in the prospectus.

In case of any significant development, a relevant announcement will be released. 

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.